Common Stock, Shares Authorized of LEXICON PHARMACEUTICALS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
LEXICON PHARMACEUTICALS, INC. quarterly Common Stock, Shares Authorized history and change rate from Q4 2010 to Q3 2025.
  • LEXICON PHARMACEUTICALS, INC. Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 450M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 450M 0 0% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 450M 0 0% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 450M 0 0% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 450M 0 0% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 450M +150M +50% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 450M +150M +50% 30 Jun 2024 10-Q 02 Aug 2024
Q1 2024 450M +150M +50% 31 Mar 2024 10-Q 14 May 2025
Q4 2023 450M +150M +50% 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 300M 0 0% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 300M 0 0% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 300M +75M +33.3% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 300M 0 0% 31 Dec 2022 10-K 25 Mar 2024
Q3 2022 300M +75M +33.3% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 300M +75M +33.3% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 225M 0 0% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 300M +75M +33.3% 31 Dec 2021 10-K 03 Mar 2023
Q3 2021 225M 0 0% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 225M 0 0% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 225M 0 0% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 225M 0 0% 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 225M 0 0% 30 Sep 2020 10-Q 30 Oct 2020
Q2 2020 225M 0 0% 30 Jun 2020 10-Q 29 Jul 2020
Q1 2020 225M 0 0% 31 Mar 2020 10-Q 27 Apr 2020
Q4 2019 225M 0 0% 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 225M 0 0% 30 Sep 2019 10-Q 30 Oct 2020
Q2 2019 225M 0 0% 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 225M 0 0% 31 Mar 2019 10-Q 27 Apr 2020
Q4 2018 225M 0 0% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 225M 0 0% 30 Sep 2018 10-Q 01 Nov 2018
Q2 2018 225M 0 0% 30 Jun 2018 10-Q 30 Jul 2018
Q1 2018 225M 0 0% 31 Mar 2018 10-Q 03 May 2018
Q4 2017 225M 0 0% 31 Dec 2017 10-K 15 Mar 2019
Q3 2017 225M 0 0% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 225M 0 0% 30 Jun 2017 10-Q 01 Aug 2017
Q1 2017 225M 0 0% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 225M 0 0% 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 225M 0 0% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 225M 0 0% 30 Jun 2016 10-Q 04 Aug 2016
Q1 2016 225M -675M -75% 31 Mar 2016 10-Q 05 May 2016
Q4 2015 225M +96.4M +75% 31 Dec 2015 10-K 06 Mar 2017
Q3 2015 225M -675M -75% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 225M -675M -75% 30 Jun 2015 10-Q 07 Aug 2015
Q1 2015 900M 0 0% 31 Mar 2015 10-Q 05 May 2015
Q4 2014 129M -771M -85.7% 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 900M 0 0% 30 Sep 2014 10-Q 06 Nov 2014
Q2 2014 900M 0 0% 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 900M 0 0% 31 Mar 2014 10-Q 08 May 2014
Q4 2013 900M 0 0% 31 Dec 2013 10-K 12 Mar 2015
Q3 2013 900M 0 0% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 900M 0 0% 30 Jun 2013 10-Q 01 Aug 2013
Q1 2013 900M 0 0% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 900M 0 0% 31 Dec 2012 10-K 07 Mar 2014
Q3 2012 900M 0 0% 30 Sep 2012 10-Q 07 Nov 2012
Q2 2012 900M 0 0% 30 Jun 2012 10-Q 02 Aug 2012
Q1 2012 900M 31 Mar 2012 10-Q 03 May 2012
Q4 2011 900M 0 0% 31 Dec 2011 10-K 11 Mar 2013
Q3 2011 900M 30 Sep 2011 10-Q 01 Nov 2011
Q2 2011 900M 30 Jun 2011 10-Q 09 Aug 2011
Q4 2010 900M 31 Dec 2010 10-K 08 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.